Mmastodon BusinessMarkets first seen 2 h ago, last 1 h ago, peak #1
Kobayashi Pharmaceutical weighs takeover offer above ¥500 billion
Original: Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat
Kobayashi Pharmaceutical, the Japanese company at the center of a supplement contamination scandal linked to suspected deaths, is reportedly considering a buyout offer valued at more than ¥500 billion. The news comes as the firm continues to face fallout over its beni-koji (red yeast rice) supplements. Reports of a potential acquisition are drawing attention to the company's future ownership and accountability over the scandal.
Why now: Reports of a multibillion-yen buyout for a company notorious for a deadly supplement scandal are newly circulating.
Rank over time, top of the chart is #1. 2 snapshots from 2 h ago to 1 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/18193